Mass Testing with Contact Tracing Compared to Test and Trace for Effective Suppression of COVID-19 in the UK: A rapid review

Author:

Mbwogge MathewORCID

Abstract

AbstractBackgroundMaking testing available to everyone and tracing contacts might be the gold standard towards the control of COVID-19, particularly when significant transmissions are without symptoms. This study evaluated the effectiveness of mass testing and contact tracing in the suppression of COVID-19 compared to conventional Test and Trace in the UK.DesignA rapid review of available evidencePrimary research questionIs there evidence that mass testing and tracing could suppress community spread of SARS-CoV-2 infections better than Test and Trace?Secondary research questionWhat is the proportion of asymptomatic cases of SARS-CoV-2 reported during mass testing interventions?MethodsLiterature was searched in September through December 2020 in Google Scholar, ScienceDirect, Mendeley and PubMed.ResultsLiterature search yielded 286 articles from Google Scholar, 20 from Science Direct, 14 from Mendeley, 27 from Pubmed and 15 through manual search. Altogether 35 articles were included, making a sample size of close to a million participants.ConclusionThere was a very low level but promising evidence of 76.9% (95% CI: 46.2 – 95.0, P=0.09) majority vote in favour of the intervention under the primary objective. The overall proportion of asymptomatic cases among those tested positive and tested sample populations under the secondary objective was 40.7% (95% CI: 38.8– 42.5) and 0.01% (95% CI: 0.01 – 0.012) respectively. Conventional test and trace should be superseded by a decentralised and regular mass rapid testing and contact tracing, championed by GP surgeries and low cost community services.

Publisher

Cold Spring Harbor Laboratory

Reference139 articles.

1. Wise J. Covid-19: Test and trace system is not fit for purpose, says Independent SAGE. BMJ [Internet]. 2020 Jun 9 [cited 2020 Sep 14];369:m2302. Available from: https://bmj.com/coronavirus/usage

2. Burns C. National Institute for Health Protection takes over COVID-19 pandemic response from PHE. Pharm J [Internet]. 2020 Aug 18 [cited 2020 Sep 7]; Available from: https://www.pharmaceutical-journal.com/news-and-analysis/news/national-institute-for-health-protection-takes-over-covid-19-pandemic-response-from-phe/20208276.article?firstPass=false

3. Dunn P , Allen L , Cameron G , Malhotra M , Alderwick H. COVID-19 policy tracker [Internet]. The Health Foundation. 2020 [cited 2021 Jan 11]. Available from: https://www.health.org.uk/news-and-comment/charts-and-infographics/covid-19-policy-tracker

4. NHS. Coronavirus (COVID-19) vaccine [Internet]. 2021 [cited 2021 Jan 11]. Available from: https://www.nhs.uk/conditions/coronavirus-covid-19/coronavirus-vaccination/coronavirus-vaccine/

5. PHE & NHSX. Daily summary: Coronavirus in the UK [Internet]. 2020 [cited 2020 Dec 5]. Available from: https://coronavirus.data.gov.uk/

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3